Iambic Announces Enchant: A Breakthrough Multimodal Transformer Model
Read more
Platform
Pipeline
Partnerships
News & Media
About
Careers
Contact
Contact
Press
back to blog
BIOS Builders #23 with Tom Miller
Press
This is some text inside of a div block.
October 11, 2023
Media Contacts
Related announcements
View All
View All
January 6, 2025
Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
Read more
January 6, 2025
Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
Read more
December 18, 2024
Iambic Therapeutics to Present at the 43rd Annual JP Morgan Healthcare Conference
Read more
December 18, 2024
Iambic Therapeutics to Present at the 43rd Annual JP Morgan Healthcare Conference
Read more
December 11, 2024
Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer
Read more
December 11, 2024
Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer
Read more